312 related articles for article (PubMed ID: 18197426)
1. Detection and monitoring of cardiotoxicity-what does modern cardiology offer?
Jurcut R; Wildiers H; Ganame J; D'hooge J; Paridaens R; Voigt JU
Support Care Cancer; 2008 May; 16(5):437-45. PubMed ID: 18197426
[TBL] [Abstract][Full Text] [Related]
2. Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.
Galderisi M; Marra F; Esposito R; Lomoriello VS; Pardo M; de Divitiis O
Cardiovasc Ultrasound; 2007 Jan; 5():4. PubMed ID: 17254324
[TBL] [Abstract][Full Text] [Related]
3. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.
Thavendiranathan P; Poulin F; Lim KD; Plana JC; Woo A; Marwick TH
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2751-68. PubMed ID: 24703918
[TBL] [Abstract][Full Text] [Related]
4. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
Hernandez-Suarez DF; López-Candales A
Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of Echocardiographic Techniques to Detect Subclinical Cancer Therapeutics-Related Cardiac Dysfunction among High-Dose Patients When Compared with Cardiac Magnetic Resonance Imaging.
Toro-Salazar OH; Ferranti J; Lorenzoni R; Walling S; Mazur W; Raman SV; Davey BT; Gillan E; O'Loughlin M; Klas B; Hor KN
J Am Soc Echocardiogr; 2016 Feb; 29(2):119-31. PubMed ID: 26678319
[TBL] [Abstract][Full Text] [Related]
6. Tissue Doppler and myocardial deformation imaging to detect myocardial dysfunction in pediatric cancer patients treated with high doses of anthracyclines.
Yağci-Küpeli B; Varan A; Yorgun H; Kaya B; Büyükpamukçu M
Asia Pac J Clin Oncol; 2012 Dec; 8(4):368-74. PubMed ID: 22898185
[TBL] [Abstract][Full Text] [Related]
7. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.
Fallah-Rad N; Walker JR; Wassef A; Lytwyn M; Bohonis S; Fang T; Tian G; Kirkpatrick ID; Singal PK; Krahn M; Grenier D; Jassal DS
J Am Coll Cardiol; 2011 May; 57(22):2263-70. PubMed ID: 21616287
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity.
de Geus-Oei LF; Mavinkurve-Groothuis AM; Bellersen L; Gotthardt M; Oyen WJ; Kapusta L; van Laarhoven HW
J Nucl Med; 2011 Apr; 52(4):560-71. PubMed ID: 21421717
[TBL] [Abstract][Full Text] [Related]
9. Detection and prevention of cardiac complications of cancer chemotherapy.
Monsuez JJ
Arch Cardiovasc Dis; 2012 Nov; 105(11):593-604. PubMed ID: 23177488
[TBL] [Abstract][Full Text] [Related]
10. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy and the heart].
Plana JC
Rev Esp Cardiol; 2011 May; 64(5):409-15. PubMed ID: 21492985
[TBL] [Abstract][Full Text] [Related]
12. The Role of Biomarkers in Cardio-Oncology.
Ananthan K; Lyon AR
J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.
Nagy AC; Tolnay E; Nagykálnai T; Forster T
Neoplasma; 2006; 53(6):511-7. PubMed ID: 17167721
[TBL] [Abstract][Full Text] [Related]
14. Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient.
Plana JC; Thavendiranathan P; Bucciarelli-Ducci C; Lancellotti P
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1173-1186. PubMed ID: 30092972
[TBL] [Abstract][Full Text] [Related]
15. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
16. [Cardiologic evaluation of patients undergoing chemotherapy].
Bordoni B; Urbinati S; Tosoni A; Labanti G; Brandes A
Monaldi Arch Chest Dis; 2014 Jun; 82(2):68-74. PubMed ID: 25845089
[TBL] [Abstract][Full Text] [Related]
17. Update on cardiotoxicity of anti-cancer treatments.
Rosa GM; Gigli L; Tagliasacchi MI; Di Iorio C; Carbone F; Nencioni A; Montecucco F; Brunelli C
Eur J Clin Invest; 2016 Mar; 46(3):264-84. PubMed ID: 26728634
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic evaluation of cardiac function after cancer chemotherapy.
Negishi T; Negishi K
J Echocardiogr; 2018 Mar; 16(1):20-27. PubMed ID: 28698984
[TBL] [Abstract][Full Text] [Related]
19. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion.
Yildirim A; Sedef Tunaoglu F; Pinarli FG; Ilhan M; Oguz A; Karadeniz C; Olguntürk R; Oguz D; Kula S
Eur J Echocardiogr; 2010 Dec; 11(10):814-22. PubMed ID: 20562426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
